Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma.
about
Identification of XAGE-1 isoforms: predominant expression of XAGE-1b in testis and tumorsThe SSX gene family: characterization of 9 complete genesAutoantibodies against GLEA2 and PHF3 in glioblastoma: tumor-associated autoantibodies correlated with prolonged survivalThe contributions of mass spectrometry to understanding of immune recognition by T lymphocytes.Differential presentation of tumor antigen-derived epitopes by MHC-class I and antigen-positive tumor cells.Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma.The SSX family of cancer-testis antigens as target proteins for tumor therapy.Identification of an HLA-A24-restricted OY-TES-1 epitope recognized by cytotoxic T-cells.Translating tumor antigens into cancer vaccinesReassessing target antigens for adoptive T-cell therapy.The VHSE-based prediction of proteasomal cleavage sitesAnalysis of the B-cell repertoire against antigens expressed by human neoplasms.Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.Towards patient-specific tumor antigen selection for vaccination.Development of a T cell receptor targeting an HLA-A*0201 restricted epitope from the cancer-testis antigen SSX2 for adoptive immunotherapy of cancer.Oncogenic functions of the cancer-testis antigen SSX on the proliferation, survival, and signaling pathways of cancer cells.Vaccines targeting the cancer-testis antigen SSX-2 elicit HLA-A2 epitope-specific cytolytic T cells.Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancerQuantification of SSX mRNA expression in human bone and soft tissue tumors using nucleic acid sequence-based amplification.A listing of human tumor antigens recognized by T cells: March 2004 update.Expression, purification and serological analysis of hepatocellular carcinoma associated antigen HCA587 in insect cellsReverse immunology approach for the identification of CD8 T-cell-defined antigens: advantages and hurdles.Targeting tumours by adoptive transfer of immune cells.Identification of T-cell epitopes for cancer immunotherapy.Enhancing cancer immunotherapy by intracellular delivery of cell-penetrating peptides and stimulation of pattern-recognition receptor signaling.An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR.Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment.Antigen-specific vaccines for cancer treatment.Tools to define the melanoma-associated immunopeptidome.Immune targets and neoantigens for cancer immunotherapy and precision medicine.Identification of an HLA-DPB1*0501 restricted Melan-A/MART-1 epitope recognized by CD4+ T lymphocytes: prevalence for immunotherapy in Asian populationsIdentification of cytotoxic T-lymphocyte epitope(s) and its agonist epitope(s) of a novel target for vaccine therapy (PAGE4).BCR-ABL fusion regions as a source of multiple leukemia-specific CD8+ T-cell epitopes.Epstein-Barr virus, B cell lymphoproliferative disease, and SCID mice: modeling T cell immunotherapy in vivo.Identification of novel tumour-associated antigens in canine mammary gland tumour.A peptide epitope derived from the cancer testis antigen HOM-MEL-40/SSX2 capable of inducing CD4⁺ and CD8⁺ T-cell as well as B-cell responses.Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer.Human Leukocyte Antigen-A Allele Distribution in Nasopharyngeal Carcinoma Patients Showing Anti-Melanoma-Associated Antigen A or Synovial Sarcoma X-2 T Cell Response in Blood.
P2860
Q24615209-416A4565-124E-4681-9065-012A9170156EQ28221334-9D0450A8-6FDA-47BE-920B-BEDE9801AA27Q28251910-1BD3B086-E13C-41CF-B5B0-96FB472BBD57Q30444065-5A22B548-4E11-4694-A3CA-B0D7111B516BQ33358727-D850FCDB-A6BF-41E7-9591-390860745B60Q34018782-B02C5206-2089-4EB5-9833-4B1E32EFF235Q34146229-7010F960-3AA8-4B57-9315-A29C98C6F690Q34469428-7B703751-A694-4FF1-9E62-F3BFACC94772Q34484042-6C98A197-5CE2-4D90-8C05-10CB798E2171Q34789569-AF718B4A-A465-439F-AE85-DC6013CB9B6DQ34990064-E85D69FD-9BCE-4999-A8E0-88BADEBB272EQ35005922-A14A9B93-851A-4BBB-9AD7-4A14BA144440Q35005935-56DC7546-E693-45C8-960C-A0B2113657B8Q35005960-612A7E84-BE9B-498F-AFCB-702D408684C9Q35135031-28E8E73F-0545-444D-B695-661ADB4EC234Q35161225-CB31051B-8A44-473E-A312-7ECE1A5A1374Q35218994-F153F965-4F88-41DB-A65A-E24724A66807Q35782660-13EB35B4-6138-4B16-8AC7-637055D8F503Q35789880-6E5C0275-DD01-4CAF-8083-8A21FC226420Q35862179-9C63C02F-81CA-4557-B88C-E05F3A865321Q36178619-419966AD-1A20-458F-85F4-8989FFDF3C83Q36471831-FB3E51D1-FBC9-4168-837B-D239EC0BC0A4Q36478870-F0263B94-60F9-4037-A064-51328F694ADDQ36870592-89759164-8797-492F-BC6B-65D7A9D244E7Q37139813-9B83E70A-57B1-4E29-B587-9022554AAEEBQ37370515-ECF9125D-F097-457B-982F-C8D840C0DB28Q37737327-3D983AAB-84E1-4A55-BEF4-9F647D8AF85EQ38284692-9C011042-F713-46A0-89F9-9BC10A9908E9Q38650013-5942C5DF-9B27-45E4-AEC5-3412A7A28A95Q39057617-35F50349-B358-4278-86E8-05B1CF109911Q39506462-8940ED04-806E-4374-A533-60C0722A55ECQ40151857-0A13FA5A-F111-4D2A-AC71-1602A67CED84Q40239641-7DEB999A-52C8-4CAF-9353-3FB3931976BCQ45365121-B963D104-7499-4116-AA62-3868F72FB374Q51261122-38CBEB78-29A0-44F1-9C3E-4DEDF8FFA618Q51562877-7EF437A8-00F7-483E-A92E-E505FF98EE86Q54582568-D44DDAA6-CF30-4F32-9A1C-1B06AF7278EAQ55364522-B3143E39-5594-49E8-AFBC-26FC992CD6B6
P2860
Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Proteasome-assisted identifica ...... iltrating metastatic melanoma.
@en
Proteasome-assisted identifica ...... iltrating metastatic melanoma.
@nl
type
label
Proteasome-assisted identifica ...... iltrating metastatic melanoma.
@en
Proteasome-assisted identifica ...... iltrating metastatic melanoma.
@nl
prefLabel
Proteasome-assisted identifica ...... iltrating metastatic melanoma.
@en
Proteasome-assisted identifica ...... iltrating metastatic melanoma.
@nl
P2093
P50
P1476
Proteasome-assisted identifica ...... iltrating metastatic melanoma.
@en
P2093
Catherine Servis
Daniel Speiser
Danila Valmori
Donata Rimoldi
Frédéric Lévy
Jean-Charles Cerottini
Maha Ayyoub
Pedro Romero
Philippe Guillaume
P304
P356
10.4049/JIMMUNOL.168.4.1717
P407
P577
2002-02-01T00:00:00Z